Skip to search formSkip to main contentSkip to account menu

progenipoietin

Known as: ProGP, Filgrastim-Fetal Liver Tyrosine Kinase-3 Fusion Protein, Flt-3 ligand/G-CSF fusion protein 
A recombinant, chimeric, dual-receptor agonist fusion protein with immunohematopoietic activity. Progenipoietin (ProGP) consists of portions of the… 
National Institutes of Health

Related topics

Related topics

1 relation

Narrower (1)

SD9427

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Use of the design‐of‐experiments approach for the development of a refolding technology for progenipoietin‐1, a recombinant human cytokine fusion protein from Escherichia coli inclusion bodies
Optimization of refolding conditions for progenipoietin was performed. The molecule has five disulfide bonds and, hence, is a… 
2005
2005
Systemic mobilization of antigen presenting cells, with a chimeric Flt-3 and G-CSF receptor agonist, during immunization of Macaca mulatta with HIV-1 antigens is insufficient to modulate immune…
2004
2004
Increase in plasmacytoid and myeloid dendritic cells by progenipoietin-1, a chimeric Flt-3 and G-CSF receptor agonist, in SIV-Infected rhesus macaques.
2003
2003
The sustained granulopoietic effect of progenipoietin encapsulated in multivesicular liposomes.
2003
2003
Mammalian cell production and purification of progenipoietin, a dual‐agonist chimaeric haematopoietic growth factor
One member of the progenipoietin (ProGP) family of engineered proteins, ProGP‐2, is a chimaeric dual cytokine receptor agonist… 
2002
2002
Cytokine-based treatment of radiation injury: potential benefits after low-level radiation exposure.
The use of growth factors (GFs) in the treatment of radiation injury has focused on enhancing recovery from acute radiation… 
2002
2002
Progenipoietin‐generated dendritic cells exhibit anti‐tumor efficacy in a therapeutic murine tumor model
Progenipoietin (ProGP‐4) is a chimeric molecule, exhibiting both Flt‐3 and granulocyte‐colony stimulating factor (G‐CSF) receptor… 
2002
2002
Conjugues de proteine « progenipoietin » chimiquement modifies
L'invention concerne des proteines « progenipoietin » (ProGP) chimiquement modifiees, preparees par la liaison d'un polymere… 
2001
2001
"Be Going To" as a Case of High Aspect
TP ---------T PROGP � PROG be -ing woll P � wall go VP � The new idea here is that PROG does not take the bare VP as its argument… 
Review
1999
Review
1999
[New cytokines and their role in supportive care].
Several cytokines stimulating hematopoiesis, mainly lineage restricted, are already widely used in supportive care to correct… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)